hiPSCs derived from pancreatic agenesis patients with GATA6 heterozygous mutations. Genome-edited hESCs (H9) and hiPSCs. Non-mutated hESCs and hiPSCs were used as isogenic controls. The gene discussed is GATA6; the disease is pancreatic agenesis.